Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene results in increased expression of NOV mRNA | increases expression | 20406850
|
C029955 |
2-nitrotoluene |
2-nitrotoluene results in decreased expression of NOV mRNA | decreases expression | 16460773
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of NOV mRNA | affects expression | 16483693
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of NOV mRNA | increases expression | 20382639
|
C099813 |
bromochloroacetic acid |
bromochloroacetic acid results in decreased expression of NOV mRNA | decreases expression | 16460773
|
D020122 |
tert-Butylhydroperoxide |
tert-Butylhydroperoxide results in decreased expression of NOV mRNA | decreases expression | 15336504
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride affects the expression of NOV mRNA | affects expression | 17484886
|
D003345 |
Corticosterone |
Corticosterone results in increased expression of NOV mRNA | increases expression | 15755911
|
D003513 |
Cycloheximide |
[Cycloheximide co-treated with Estradiol] results in decreased expression of NOV mRNA | affects cotreatment|decreases expression | 15072547
|
D003513 |
Cycloheximide |
Cycloheximide results in increased expression of NOV mRNA | increases expression | 15072547
|
D004041 |
Dietary Fats |
Dietary Fats results in increased expression of NOV mRNA | increases expression | 18042831
|
D004958 |
Estradiol |
[Cycloheximide co-treated with Estradiol] results in decreased expression of NOV mRNA | affects cotreatment|decreases expression | 15072547
|
D004958 |
Estradiol |
Estradiol results in decreased expression of NOV mRNA | decreases expression | 15072547 18984771
|
D005419 |
Flavonoids |
Flavonoids results in increased expression of NOV mRNA | increases expression | 18035473
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of NOV mRNA | increases expression | 16510598
|
C070081 |
fulvestrant |
fulvestrant results in increased expression of NOV mRNA | increases expression | 18984771 15072547
|
C070081 |
fulvestrant |
fulvestrant results in increased expression of NOV protein | increases expression | 18984771
|
C475919 |
hydroxytamoxifen |
hydroxytamoxifen results in decreased expression of NOV mRNA | decreases expression | 15072547
|
D007529 |
Isoflavones |
Isoflavones affects the expression of NOV mRNA | affects expression | 16365062
|
D008748 |
Methylcholanthrene |
Methylcholanthrene results in increased expression of NOV mRNA | increases expression | 20713471
|
C041786 |
palm oil |
palm oil results in increased expression of NOV mRNA | increases expression | 18042831
|
C076994 |
perfluorooctane sulfonic acid |
perfluorooctane sulfonic acid results in increased expression of NOV mRNA | increases expression | 17560707
|
C023036 |
perfluorooctanoic acid |
perfluorooctanoic acid results in increased expression of NOV mRNA | increases expression | 17560707
|
D020849 |
Raloxifene |
[Raloxifene co-treated with ESR1 protein] results in decreased expression of NOV mRNA | affects cotreatment|decreases expression | 19059307
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of NOV mRNA | increases expression | 12016162
|
D013629 |
Tamoxifen |
[Tamoxifen co-treated with ESR1 protein] results in decreased expression of NOV mRNA | affects cotreatment|decreases expression | 19059307
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.40 | 14745880 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.41 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.32 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.32 | 17638652 |
MESH:D000236 |
Adenoma |
|
Methylcholanthrene |
3.41 | 10545420 6695378 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.55 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.75 | 16712894 17306315 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
4.45 | 17451421 17308373 |
MESH:D000505 |
Alopecia |
|
Isoflavones |
4.60 | 17569567 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.51 | 15800139 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.58 | 17963324 16511603 15504547 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.74 | 15238619 |
MESH:D050197 |
Atherosclerosis |
|
Methylcholanthrene |
3.36 | 11922910 |
MESH:D001284 |
Atrophy |
|
fulvestrant |
4.70 | 11514358 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.32 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
3.68 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.68 | 17018787 12948864 14630087 17289903 16675129 19861407 17261762 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
3.68 | 16595493 18608205 15136595 16110121 19217205 18357371 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
fulvestrant |
3.68 | 18984771 |
MESH:D001943 |
Breast Neoplasms |
|
Methylcholanthrene |
3.68 | 17474063 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
3.68 | 16912660 15775269 16837676 17242785 15572757 17952589 17893378 17440819 17595753 15758505 17049068 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
3.68 | 16818667 19221464 19244106 19155303 17242785 19011961 19059307 18629630 18984771 17440819 20390343 19115204 16873071 19200415 16273361 19084267 19103187 19189210 19410462 20135344 21138602 11161223 18425577 21152245 20005174 18351453 19487384 18815881 18821012 20544844 19288272 15668708 18997820 17893378 19142967 15565566 17049068 18855134 20065188 20859285 17261762 19189212 16202921 19066611 19289846 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.31 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
3.63 | 16050911 15673190 16192424 16227642 18705752 3786805 16011737 15721981 16097048 15700767 10355542 16124888 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.52 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
8.21 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Methylcholanthrene |
8.21 | 10545420 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.35 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
11.07 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
11.07 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
11.07 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
11.07 | 16799960 18930000 17971768 16332177 17088986 17045692 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
11.07 | 15276417 16507464 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
11.07 | 16924424 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
2.95 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
4.61 | 16757204 17066447 18986760 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.61 | 18572023 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
9.05 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
9.05 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Isoflavones |
7.47 | 17689850 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
7.47 | 15775269 |
MESH:D002430 |
Cecal Neoplasms |
|
2-nitrotoluene |
5.54 | 14688030 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
20.00 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
20.00 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
20.00 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylcholanthrene |
20.00 | 16192471 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
20.00 | 20056578 19524636 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
4.47 | 15800139 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.21 | 17169374 16510598 15001691 18772588 17016597 17725105 17018589 17287894 16340194 17172411 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.89 | 17695437 18949393 16391804 18383874 17016601 20501625 17094418 15148649 14970324 18509181 15289873 18288408 17255274 16303861 16524972 16331619 17594712 17454858 18448328 16282729 18802399 17401013 |
MESH:D015179 |
Colorectal Neoplasms |
|
Isoflavones |
2.89 | 17116718 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.87 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.64 | 16733453 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.21 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.03 | 17474826 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
14.27 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
14.27 | 17308373 17451421 15920148 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
14.27 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
3.74 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
3.74 | 2869522 10915739 6884620 9327722 10092053 17522070 7120509 11566570 3786805 15998439 3732212 16177239 19336974 15968718 15027814 16227642 7179309 7440962 21278145 4309450 6623471 19085960 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.34 | 18367378 |
MESH:D004487 |
Edema |
|
perfluorooctanoic acid |
6.84 | 12083418 17259670 |
MESH:D004487 |
Edema |
|
Raloxifene |
6.84 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
8.75 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
8.75 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.06 | 19148513 18566989 11473722 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
7.06 | 16202921 19155303 20544844 17893378 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
4.38 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.38 | 17638652 15173087 16481741 16785472 16337965 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
17.67 | 15959796 19224547 12631006 16045604 12795759 61145 17595544 16239168 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
17.67 | 19551842 17967931 18296743 19004024 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
17.67 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
17.67 | 14986274 19224547 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.14 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.38 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.03 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylcholanthrene |
4.79 | 14633661 10962813 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
8.31 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
8.31 | 18296743 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.53 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
perfluorooctane sulfonic acid |
4.16 | 17162496 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.81 | 16145905 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.28 | 15162350 15102660 18337622 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.43 | 11110106 |
MESH:D006394 |
Hemangiosarcoma |
|
2-nitrotoluene |
4.94 | 13678655 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
3.45 | 19110552 19900420 |
MESH:D006529 |
Hepatomegaly |
|
perfluorooctanoic acid |
3.95 | 3609246 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.88 | 15709030 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.03 | 12676792 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
9.92 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Isoflavones |
9.92 | 17290160 14716179 |
MESH:D006930 |
Hyperalgesia |
|
perfluorooctanoic acid |
3.73 | 12083418 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
4.38 | 16899240 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.45 | 21332399 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.47 | 21332399 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.81 | 15787275 17577099 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.94 | 15338365 |
MESH:D007248 |
Infertility, Male |
|
fulvestrant |
6.77 | 11514358 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.77 | 15346721 12646999 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
11.37 | 20412841 |
MESH:D007249 |
Inflammation |
|
Flavonoids |
11.37 | 17296493 |
MESH:D007249 |
Inflammation |
|
perfluorooctanoic acid |
11.37 | 12083418 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
11.37 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.04 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
7.04 | 16393666 16627594 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
5.82 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
5.82 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
16.75 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
16.75 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
16.75 | 16985049 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
16.75 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.35 | 16973256 |
MESH:D007984 |
Leydig Cell Tumor |
|
perfluorooctanoic acid |
5.08 | 8812269 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.05 | 15342952 17567588 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
6.35 | 16943688 17157831 16239168 11903743 21278145 16221502 11408273 17174718 17334410 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.35 | 18296743 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
3.40 | 15893842 17761835 17823541 18395095 18210741 15123356 12389079 14724832 14620537 12609069 17557913 12958196 12666154 14716833 14512876 11481614 17922224 12667390 15338365 18263696 16116963 16027843 18395914 15876570 15931870 15730626 18166357 18205269 17565644 16097048 17714472 18279442 17805973 12632514 18317297 12586293 12445418 18420326 16015684 20821823 15925388 16192424 17698563 17631135 12898905 17976157 15650968 15996030 18472332 16033810 17869086 17708605 18376398 17766677 15818738 18187930 17481882 12445421 15057751 12741479 14748882 18339082 12546737 17721639 18412020 10355542 17944888 17525996 16136751 15673190 18054572 17640975 14716496 13678700 16638106 15052691 18277467 15959796 18481824 15362042 16248980 17900296 18472094 18418968 15370692 18156304 18705752 18429990 18006644 12632512 18251166 16011737 12649538 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
3.40 | 14659978 14716833 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.40 | 18564211 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
2.05 | 15720792 15830285 16246199 16964402 17285989 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
4.01 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.56 | 14706259 16899240 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
17.25 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
17.25 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
17.25 | 18383874 17045692 16603448 15113037 |
MESH:D008113 |
Liver Neoplasms |
|
perfluorooctanoic acid |
17.25 | 14757943 18709148 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
17.25 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
17.25 | 16684651 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.39 | 6135515 2876786 2876784 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
9.39 | 15583823 12014681 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Methylcholanthrene |
9.39 | 598648 1399818 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.07 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
4.75 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Methylcholanthrene |
4.75 | 7750092 6695378 16271038 11893704 16337739 17909032 1399818 10545420 21163286 20512841 15390079 9230183 20970405 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
4.75 | 19931552 17306315 17077188 16712894 15276417 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
4.75 | 18625569 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.64 | 15086387 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
3.61 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
9.51 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
9.51 | 11408345 11807958 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
9.51 | 11731420 19196723 14580682 19196722 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
12.14 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
12.14 | 19453300 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.23 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.23 | 12393984 19393235 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.03 | 15990972 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
5.40 | 15863610 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.51 | 18986760 16757204 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.33 | 16497877 |
MESH:D019042 |
Muscle Neoplasms |
|
2-nitrotoluene |
6.53 | 13678655 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.16 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
5.40 | 16343187 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.71 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.49 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.47 | 19410462 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
4.94 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
4.94 | 11559025 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.52 | 20056578 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
3.85 | 19200415 19189210 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.58 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
3.50 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
3.05 | 12854658 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.34 | 16436463 |
MESH:D052556 |
Niemann-Pick Disease, Type C |
|
perfluorooctanoic acid |
4.80 | 9802331 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
2.25 | 11836018 21332399 20518802 19632207 18674790 17217161 18457598 16723640 20132043 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
3.30 | 16049721 |
MESH:D010024 |
Osteoporosis |
|
Isoflavones |
7.34 | 16562857 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
7.34 | 15775268 17882678 19059307 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.08 | 17823083 17893378 15758505 15579764 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
4.68 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.68 | 15276417 17306315 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
2.61 | 19003803 16929163 16500647 15113037 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
perfluorooctanoic acid |
4.24 | 17132714 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.75 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.89 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Isoflavones |
1.89 | 16365062 17571952 17219775 17374662 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
1.89 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
1.89 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
1.89 | 15067354 |
MESH:D011693 |
Purpura |
|
Raloxifene |
5.40 | 15770314 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.88 | 16160472 15538739 18286688 18722050 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
2.44 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
5.60 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
tert-Butylhydroperoxide |
5.60 | 8532709 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.14 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
3.89 | 19457130 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.68 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.00 | 16424979 17498489 17522103 19015929 17172411 16951190 19084572 15786421 18396642 18567086 |
MESH:D020521 |
Stroke |
|
Raloxifene |
3.70 | 16837676 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
13.21 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
13.21 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
3.85 | 16280240 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
11.46 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
11.46 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
11.46 | 11723127 16452187 16712894 17306315 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
11.46 | 8653321 16712894 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.17 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
9.04 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
9.04 | 11813266 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.27 | 17056641 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.06 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
5.40 | 16343187 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.61 | 16723640 |